Last reviewed · How we verify
Baiya SARS-CoV-2 Vax 1
At a glance
| Generic name | Baiya SARS-CoV-2 Vax 1 |
|---|---|
| Sponsor | Baiya Phytopharm Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Baiya SARS-CoV-2 Vax 1 CI brief — competitive landscape report
- Baiya SARS-CoV-2 Vax 1 updates RSS · CI watch RSS
- Baiya Phytopharm Co., Ltd. portfolio CI